-
-
-
-
-
-
-
MKT Capital Applauds Aurinia Pharmaceuticals’ Management Transition
-
-
-
-
-
-
-
Aurinia to present LUPKYNIS data at medical conferences
-
-
-
-
-
-
-
TD Cowen Reiterates Buy Rating on Aurinia Pharmaceuticals (AUPH)
-
-
-
-
-
-
-
Aurinia Pharmaceuticals (AUPH) Tops Q3 EPS by 8c
-
-
-
-
-
-
-
Aurinia Pharmaceuticals (AUPH) Announces First Participant Dosed in AUR200 Single Ascending Dose Trial
-
-
459,058 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

